These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7516263)

  • 1. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients.
    Bronowicki JP; Vetter D; Dumas F; Boudjema K; Bader R; Weiss AM; Wenger JJ; Boissel P; Bigard MA; Doffoel M
    Cancer; 1994 Jul; 74(1):16-24. PubMed ID: 7516263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
    Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G
    J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
    Chung JW; Park JH; Han JK; Choi BI; Han MC
    AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas.
    Saccheri S; Lovaria A; Sangiovanni A; Nicolini A; De Fazio C; Ronchi G; Fasani P; Del Ninno E; Colombo M
    J Vasc Interv Radiol; 2002 Oct; 13(10):995-9. PubMed ID: 12397120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
    Wickenhöfer R; Hasan I; Schüller H; Reiser M; Hartlapp JH
    Rofo; 1992 Apr; 156(4):328-32. PubMed ID: 1373966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
    Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma.
    Bronowicki JP; Boudjema K; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Jaeck D; Boissel P; Bigard MA; Gaucher P; Vetter D; Doffoel M
    J Hepatol; 1996 Mar; 24(3):293-300. PubMed ID: 8778195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow-up.
    Ngan H; Lai CL; Fan ST; Lai EC; Yuen WK; Tso WK
    J Vasc Interv Radiol; 1996; 7(3):419-25. PubMed ID: 8761824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
    Phornphutkul K; Handagoon P; Sirivanichai C; Senarat S; Nakamura H
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1239-46. PubMed ID: 1325144
    [No Abstract]   [Full Text] [Related]  

  • 12. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.
    Farinati F; De Maria N; Marafin C; Herszènyi L; Del Prato S; Rinaldi M; Perini L; Cardin R; Naccarato R
    Dig Dis Sci; 1996 Dec; 41(12):2332-9. PubMed ID: 9011438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role.
    Chung JW; Park JH; Han JK; Choi BI; Kim TK; Han MC
    J Vasc Interv Radiol; 1998; 9(3):495-500. PubMed ID: 9618112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of transcatheter oily chemoembolization for hepatocellular carcinoma assessed by computed tomography: role of iodized oil.
    Oi H; Kishimoto H; Matsushita M; Katsushima S; Tateishi H; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-56-S6-60. PubMed ID: 9151918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
    Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
    AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
    Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
    [No Abstract]   [Full Text] [Related]  

  • 20. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis.
    Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K
    Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.